Antagonizing Toll-like receptor-7 lowers the growth rate of CSCs in hepatocellular carcinoma through TLR7-IKK-NF-kB-IL6 signaling pathway [71]. The gene discussed is TLR7; the disease is hepatocellular carcinoma.